A coder posted this question in a billing community forum: what CPT code is everyone using for injections of Juvederm Ultra XC to bilateral breasts? They had done their homework and landed on the 11950 to 11954 range based on the volume injected. Their instinct on the code family was correct. But the real answer to this question goes further than picking the right code. It involves a payer coverage wall that most billers hit hard the first time they encounter it.
Key Takeaways
- CPT codes 11950, 11951, 11952, and 11954 are the correct procedural codes for subcutaneous injection of filling material, selected based on total volume injected.
- Juvederm Ultra XC is classified by the FDA strictly as a facial aesthetic device. No approved breast augmentation indication exists.
- Nearly all commercial payers and Medicare classify Juvederm injections for breast augmentation as cosmetic and non-covered.
- Most of these cases result in a patient out-of-pocket (OOP) arrangement, not an insurance claim submission.
- When submitting to insurance is required, the HCPCS drug code pairing and a GY modifier strategy are your two key billing decisions.
The 11950 to 11954 Range: Your Instinct Was Right
The CPT code family from 11950 to 11954 covers subcutaneous injection of filling material. These are the codes that apply when a provider injects any dermal or subcutaneous filler, whether collagen, hyaluronic acid, or similar materials, directly into the tissue.
The descriptor language says “filling material (eg, collagen)” but the parenthetical is an example, not a restriction. Hyaluronic acid products like Juvederm fall within the scope of these codes.
Selection within the range is purely volume-driven:
| CPT Code | Volume Injected | Descriptor |
|---|---|---|
| 11950 | 1 cc or less | Subcutaneous injection of filling material; 1 cc or less |
| 11951 | 1.1 cc to 5.0 cc | Subcutaneous injection of filling material; 1.1 to 5.0 cc |
| 11952 | 5.1 cc to 10.0 cc | Subcutaneous injection of filling material; 5.1 to 10.0 cc |
| 11954 | Over 10.0 cc | Subcutaneous injection of filling material; over 10.0 cc |
For bilateral breast injections, total the volume across both sides. If a provider injects 3 cc per breast for a bilateral session, the total is 6 cc, which puts you at 11952. Do not split the bilateral volume and bill two separate codes. The volume-based CPT hierarchy is designed for the total amount injected during the session.
The Drug Code Pairing: What Goes With the Procedure Code
The CPT code captures the injection service. You also need to report the drug or product separately using an HCPCS code. Juvederm Ultra XC does not have a dedicated HCPCS code tied specifically to it as a named product for breast use. The options billers use are J3490 (unclassified drugs) or J3590 (unclassified biologics). Some facilities have also seen Q2026 or Q2028 used for hyaluronic acid products depending on which specific Juvederm variant is being reported.
When using J3490 or J3590, the claim will require a narrative describing the drug, the concentration, and the units administered. Most payers demand this as part of the submission when an unclassified HCPCS code is on the claim.
The Coverage Wall: Why Most of These Claims Do Not Go Through Insurance
Here is where the conflicting information in the original forum question comes from. Coders find the correct CPT codes, submit the claim, and then run into an immediate non-covered denial. The confusion is not about the code. It is about the coverage position on the product itself.
Juvederm Ultra XC is a Class III medical device that received FDA premarket approval (PMA) for facial aesthetic applications only. The FDA approved Juvederm and its variants strictly for mid-to-deep dermal implantation for facial wrinkles, folds, lip augmentation, and midface volume loss. Breast augmentation is not an approved indication, which makes any breast injection an off-label use.
Major commercial payers have published coverage policies that treat Juvederm injections for breast augmentation as cosmetic and non-covered. Medical Mutual explicitly classifies Juvederm, along with Restylane, Sculptra, Kybella, Radiesse, Botox Cosmetic, Daxxify, and Jeuveau, as cosmetic products not eligible for reimbursement. Cigna’s coverage policy on breast reconstruction lists Juvederm as experimental and investigational when used for breast or areolar applications, citing insufficient published evidence in the peer-reviewed literature to support safety, efficacy, or clinical utility for those indications. LifeWise and Health Partners maintain similar non-coverage positions across their cosmetic and reconstructive procedure policies.
Medicare follows the same logic. The Medicare Benefit Policy Manual, Chapter 16, excludes cosmetic surgery from coverage. When a procedure is performed for a cosmetic reason, the claim is non-covered under statute, not just payer discretion. For Medicare claims where a denial is needed for ABN purposes, a GY modifier can be appended to indicate the service is statutorily excluded.
How Plastic Surgery Billers Actually Handle This
In most plastic surgery and medical spa billing departments, Juvederm for breast augmentation never hits an insurance claim form at all. The standard workflow is patient-pay OOP from the start. The provider quotes the cost, collects before or at the time of service, and no claim is submitted.
The situations where a claim does get submitted are narrow. Occasionally a patient has supplemental coverage or a benefit plan with a cosmetic rider. More commonly, a biller new to plastics attempts to submit assuming the 11950 to 11954 codes will process. They then receive a denial citing cosmetic exclusion, non-covered service, or investigational status, depending on how the payer’s system is configured to respond.
If you are coding for a plastics or aesthetic practice and you receive a request to bill Juvederm breast injections to insurance, the first step is to check the specific payer’s LCD or coverage policy before submitting. A quick call to the payer’s provider line asking whether CPT 11950 to 11954 is covered for hyaluronic acid filler in the breast, citing the patient’s plan, will tell you within minutes whether submission is worth the effort.
For practices that do occasionally submit, the complete billing unit for this service typically looks like this:
| Billing Element | Code / Action | Notes |
|---|---|---|
| Procedure code | 11950, 11951, 11952, or 11954 | Based on total cc injected bilateral |
| Drug code | J3490 or J3590 | Narrative description of product required |
| Diagnosis code | Z41.1 or applicable cosmetic ICD-10 | Cosmetic encounter code; expect denial on most plans |
| Medicare modifier | GY (if Medicare) | Statutory exclusion; used when formal denial needed for patient records |
| Bilateral indicator | Modifier 50 or LT/RT | Apply per payer billing preference |
Why Coders Get Conflicting Information on This
The conflicting information pattern the original poster described is predictable given how this procedure sits at the intersection of three separate billing decisions: choosing the right CPT code, pairing the correct drug HCPCS, and then running into a coverage wall that has nothing to do with either of those choices.
Someone who only answered the CPT selection question correctly would say “use 11950 to 11954 based on volume” and stop there. That answer is technically correct but operationally incomplete. Someone who encountered the payer denial first would say “these claims never pay, just do patient OOP” and skip the coding question entirely. A third person working in a practice that occasionally does submit might reference a workflow built around a specific payer’s LCD that differs from what another biller found in a different region or plan type.
All three perspectives are drawn from real billing experience. None of them is wrong. They are just answering different parts of the same question depending on what they have encountered in their own AR.
The Bottom Line for Your Billing Department
If the provider is injecting Juvederm Ultra XC into the bilateral breasts, your CPT code selection follows the volume threshold table above. Your drug code is J3490 or J3590 with a narrative. Your ICD-10 is a cosmetic encounter code, most commonly Z41.1 for encounter for cosmetic surgery.
Before you submit to any payer, pull the LCD for CPT 11950 and the payer’s coverage policy on injectable fillers and cosmetic procedures. In most cases you will confirm what plastics billers already know from working these cases: the payer will not cover it, the correct outcome is patient OOP, and the claim is either not submitted or submitted only to generate a formal denial for the patient’s benefit file.
The code question has a clean answer. The coverage question is where the real work sits.
GY modifier on Medicare claims
Z41.1 ICD-10 cosmetic encounter
Frequently Asked Questions
Which CPT code do you use for Juvederm injection into the breast?
Use CPT codes 11950 through 11954 based on the total volume injected. Under 1 cc uses 11950, 1.1 to 5.0 cc uses 11951, 5.1 to 10.0 cc uses 11952, and over 10.0 cc uses 11954. For bilateral breast injections, total the volume from both sides before selecting the code.
Is Juvederm breast augmentation covered by insurance?
No. Nearly all commercial payers and Medicare classify Juvederm injections for breast augmentation as cosmetic and non-covered. The FDA has only approved Juvederm for facial aesthetic applications, and breast injection is considered off-label, investigational, and cosmetic by major payers including Cigna, UHC, and Medical Mutual.
What HCPCS drug code goes with Juvederm injections?
Use J3490 (unclassified drugs) or J3590 (unclassified biologics) and include a narrative description of the product, concentration, and units. Juvederm does not have a dedicated HCPCS drug code for off-label breast use.
Should I bill bilateral Juvederm breast injections as two units or one?
Total the volume across both sides and select one CPT code from the 11950 to 11954 range based on the combined volume. If you also need to indicate bilateral treatment, apply modifier 50 or LT/RT per the payer’s billing preferences.
What happens if I submit Juvederm breast injection claims to insurance?
Expect a non-covered or cosmetic denial in most cases. The appropriate workflow is to confirm payer coverage before submitting, and in most plastics practices, to collect patient OOP payment upfront. If submitting to Medicare and a formal denial is needed for the patient’s records, append the GY modifier to indicate the service is a statutory exclusion.
Manikandan is a Revenue Cycle Management (RCM) specialist with over 10 years of hands-on experience in US healthcare billing. He has worked extensively with commercial payers, Medicare, and Medicaid across multiple specialties including surgery, orthopedics, and radiology. Manikandan founded Medical Billing 101 to provide free, accurate denial code guides, CPT coding references, and Medicare billing resources for US medical billing professionals.